NasdaqGS - Nasdaq Real Time Price USD

Insulet Corporation (PODD)

Compare

Time to buy PODD?

256.42

+0.95

+(0.37%)

At close: April 15 at 4:00:00 PM EDT

253.64

-2.78

(-1.09%)

Pre-Market: 5:17:47 AM EDT

Time to buy PODD?

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%, while the baseline 10% tariffs remained in place for most countries. This reminded investors that the global trade environment remained volatile, limiting the potential for sustained market gains.

StockStory 5 days ago

HAE

UFPT

TFX
-2.71%
Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?

Insulet (PODD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks 6 days ago

PODD
+0.37%
BLFS
5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout

Despite Extreme volatility, these five stocks have provided more than 4% returns past month. These are: SFM, UNH, SRAD, GME, PODD.

Zacks 6 days ago

SFM

SRAD

UNH
PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Insulet announces the commercial launch of Omnipod 5 AID system in Canada, with Dexcom G6 and G7 CGM sensor compatibility.

Zacks 7 days ago

PODD
+0.37%
BSX

CAH
Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

Let’s dig into the relative performance of Masimo (NASDAQ:MASI) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

StockStory 8 days ago

MASI
-1.01%
IRTC
-2.37%
DXCM
+2.73%
This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

This medical device stock is in a base and its relative strength line hit a 52-week high. Insulet's insulin pump is now available in Canada.

Investor's Business Daily 8 days ago

PODD
+0.37%
Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7%

Insulet (NasdaqGS:PODD) recently launched the Omnipod 5 system in Canada, marking a noteworthy advancement in diabetes management with public reimbursement already underway in some provinces. Despite this development, the stock dropped 2.6% over the last month. The decline occurred amid broad market volatility, with the Dow Jones and S&P 500 facing sharp losses due to tariff uncertainties and economic recession fears. Additionally, the company's issuance of senior notes and the departure of...

Simply Wall St. 8 days ago

PODD
+0.37%
Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that Omnipod 5 is now commercially available in Canada. Omnipod 5 is the first tubeless, waterproof* Automated Insulin Delivery (AID) System approved for use in Canada for people with type 1 diabetes ages two years and above.

CNW Group 8 days ago

PODD
+0.37%
Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

ACTON, Mass., April 03, 2025--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced plans to release its financial results for the first quarter of 2025 on May 8, 2025, after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

Business Wire 13 days ago

PODD
+0.37%
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers.

StockStory 13 days ago

IRTC
-2.37%
DXCM
+2.73%
MASI
-1.01%
3 Reasons Investors Love Insulet (PODD)

Over the past six months, Insulet has been a great trade. While the S&P 500 was flat, the stock price has climbed by 14.6% to $265.87 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.

StockStory 20 days ago

PODD
+0.37%
^GSPC
Insulet Gains 62.9% in a Year: What's Driving the Stock?

PODD's shares rise on the back of its innovative Omnipod 5 system and impressive market expansion. However, the unfavorable macroeconomic scenario is concerning.

Zacks 22 days ago

PODD
+0.37%
Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5%

Insulet (NasdaqGS:PODD) experienced a 5% increase in share price over the past week, a period marked by significant financial advancements and product developments. The company's successful closure of $450 million in 6.50% Senior Notes and the amendment of its Credit Agreement to increase revolving commitments to $500 million likely bolstered investor confidence. The announcement of new clinical data revealing improvements in HbA1c levels through the Omnipod 5 AID System further positioned...

Simply Wall St. 24 days ago

PODD
+0.37%
PODD Stock Gains Following the Launch of Omnipod 5 in Australia

Insulet announces the commercial launch of Omnipod 5 AID system in Australia, with Dexcom G6 and G7 CGM sensor compatibility.

Zacks 25 days ago

PODD
+0.37%
MASI
-1.01%
BSX
Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

StockStory 26 days ago

PODD
+0.37%
DXCM
+2.73%
IRTC
-2.37%
PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5

Insulet unveils positive RADIANT trial clinical data for its Omnipod 5 at the 18th international conference on ATTD.

Zacks 26 days ago

PODD
+0.37%
CAH

BSX
LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day

LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day.

Zacks 26 days ago

TREE

PODD
+0.37%
MDT
Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data

Medical device companies presented new data this week at the Advanced Technologies & Treatments for Diabetes conference.

MedTech Dive 27 days ago

PODD
+0.37%
TNDM
+3.99%
Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

ACTON, Mass., March 19, 2025--Insulet's RADIANT trial demonstrates meaningful glycemic improvements with Omnipod 5 AID following direct transition from multiple daily injections

Business Wire 27 days ago

PODD
+0.37%
3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan

Tariffs are shaking up the Medical Device industry, but SYK, MDT & PODD are poised to thrive. Here's why three key players remain strong despite rising trade tensions.

Zacks 27 days ago

PODD
+0.37%
MDT

SYK

Performance Overview

Return	PODD	S&P 500 (^GSPC)
YTD	-1.78%	-8.25%
1-Year	+47.42%	+6.61%
3-Year	-2.69%	+22.86%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Insulet Corporation (PODD)

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

Strength Seen in Insulet (PODD): Can Its 7.2% Jump Turn into More Strength?

5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market Rout

PODD Stock Benefits From the Launch of Omnipod 5 in Canada

Q4 Patient Monitoring Earnings Review: First Prize Goes to Masimo (NASDAQ:MASI)

This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative Strength

Insulet (NasdaqGS:PODD) Launches Omnipod 5 In Canada As Shares Dip 7%

Insulet Launches Omnipod® 5 Automated Insulin Delivery System in Canada, a Revolutionary New Technology for People Living with Type 1 Diabetes Ages Two Years and Above

Insulet to Announce First Quarter 2025 Financial Results on May 8, 2025

Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks

3 Reasons Investors Love Insulet (PODD)

Insulet Gains 62.9% in a Year: What's Driving the Stock?

Insulet (NasdaqGS:PODD) Completes US$450 Million Debt Financing; 7 Day Share Price Up 5%

PODD Stock Gains Following the Launch of Omnipod 5 in Australia

Patient Monitoring Stocks Q4 In Review: Insulet (NASDAQ:PODD) Vs Peers

PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5

LendingTree and AMC Networks have been highlighted as Zacks Bull and Bear of the Day

Dexcom shares 15-day CGM data; Tandem posts Type 2 pivotal data

Insulet’s RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily Injections

3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA Slogan

Performance Overview